https://oncologyvoicenetwork.com/read/your-launch-team-is-misreading-your-own-data2026-08-10weekly0.8https://oncologyvoicenetwork.com/img/insights_output/insight_0008.jpgYour Launch Team Is Misreading Your Own Data.Your Launch Team Is Misreading Your Own Data.https://oncologyvoicenetwork.com/read/clinical-trial-design-fails-in-the-details-not-science2026-08-09weekly0.8https://oncologyvoicenetwork.com/img/insights_output/insight_0002.jpgClinical Trial Design Fails in the Details. Not Science.Clinical Trial Design Fails in the Details. Not Science.https://oncologyvoicenetwork.com/read/approval-without-access-is-failure2026-08-09weekly0.8https://oncologyvoicenetwork.com/img/insights_output/insight_0006.jpgApproval Without Access Is Failure.Approval Without Access Is Failure.https://oncologyvoicenetwork.com/read/data-generation-is-not-the-problem-data-translation-is2026-08-09weekly0.8https://oncologyvoicenetwork.com/img/insights_output/insight_0005.jpgData Generation Is Not the Problem. Data Translation Is.Data Generation Is Not the Problem. Data Translation Is.https://oncologyvoicenetwork.com/read/disconnecting-preclinical-and-clinical-teams-creates-blind-spots2026-08-08weekly0.8https://oncologyvoicenetwork.com/img/insights_output/insight_0011.jpgDisconnecting Preclinical and Clinical Teams Creates Blind Spots.Disconnecting Preclinical and Clinical Teams Creates Blind Spots.https://oncologyvoicenetwork.com/read/silos-arent-a-structural-problem-theyre-an-incentive-problem2026-08-05weekly0.8https://oncologyvoicenetwork.com/img/insights_output/insight_0001.jpgSilos Aren’t a Structural Problem. They’re an Incentive Problem.Silos Aren’t a Structural Problem. They’re an Incentive Problem.https://oncologyvoicenetwork.com/read/speed-to-market-can-destroy-long-term-value2026-08-05weekly0.8https://oncologyvoicenetwork.com/img/insights_output/insight_0007.jpgSpeed to Market Can Destroy Long-Term Value.Speed to Market Can Destroy Long-Term Value.https://oncologyvoicenetwork.com/read/the-industry-cuts-programs-too-early-and-learns-too-little2026-08-05weekly0.8https://oncologyvoicenetwork.com/img/insights_output/insight_0004.jpgThe Industry Cuts Programs Too Early. And Learns Too Little.The Industry Cuts Programs Too Early. And Learns Too Little.https://oncologyvoicenetwork.com/read/patient-centricity-is-a-myth-without-patient-inclusion-12026-08-05weekly0.8https://oncologyvoicenetwork.com/img/insights_output/insight_0003.jpgPatient Centricity Is a Myth Without Patient Inclusion.Patient Centricity Is a Myth Without Patient Inclusion.https://oncologyvoicenetwork.com/read/trials-fail-because-they-ignore-real-life2026-08-05weekly0.8https://oncologyvoicenetwork.com/img/insights_output/insight_0009.jpgTrials Fail Because They Ignore Real Life.Trials Fail Because They Ignore Real Life.https://oncologyvoicenetwork.com/read/copy-paste-development-is-a-hidden-industry-risk2026-08-05weekly0.8https://oncologyvoicenetwork.com/img/insights_output/insight_0010.jpgCopy-Paste Development Is a Hidden Industry Risk.Copy-Paste Development Is a Hidden Industry Risk.